EUVIMEDEUVIMED entdecken
Crossref

Triptolide injection reduces Alzheimer's disease‐like pathology in mice

Rui Mao, Shihao Xu, Guangwen Sun, Yingying Yu, Zhiyi Zuo, Yuanyuan Wang, Kun Yang, Zhen Zhang, Wenqiong Yang

Synapse · 2023

DOI: 10.1002/syn.22261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synapse, 2023. Verfasst von Rui Mao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Diterpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triptolide is an epoxidized diterpene lactone isolated from Tripterygium wilfordii . Studies have shown that triptolide exerts organ‐protective effects. However, it remains unknown whether triptolide improves Alzheimer's disease (AD)‐like presentations. Thirty healthy 8‐week‐old male C57BL/6J mice were randomly divided into control ( n = 10), model ( n = 10), and triptolide ( n = 10) groups. Amyloid‐β (Aβ)42 was injected bilaterally into the ventricles of mice in the model group. Triptolide was injected intraperitoneally daily after injecting Aβ42 (a total of 30 days) in the triptolide group. Learning and memory were tested using the Morris water maze test. The deposition of Aβ42 in the hippocampus was detected using immunohistochemical staining. In the hippocampus, three synaptic‐associated proteins—gephyrin, collybistin, and GABRA 1 —were detected by western blotting. Furthermore, we used ELISA to detect proinflammatory cytokines, including TNF‐α and IL‐1β, in the blood and hippocampus. Moreover, superoxide dismutase (SOD), malondialdehyde (MDA), and GSH levels were measured using the corresponding kits. We found that triptolide improved spatial learning and memory in AD‐like mice. Additionally, triptolide maintained the expression of gephyrin, collybistin, and GABRA 1 and reduced Aβ in these mice. Additionally, triptolide reduced the expression of inflammatory cytokines and decreased oxidative damage in AD‐like mice. Our study suggests that triptolide attenuates AD‐like changes in the mouse brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDiterpenesMiceMaleAnimalsMice, Inbred C57BLAmyloid beta-PeptidesHippocampusCytokinesDisease Models, AnimalEpoxy CompoundsPhenanthrenes

Stichwörter der Autor:innen

Alzheimer's diseaseGABAARcollybistingephyrininflammationoxidative stresspostsynaptic structuretriptolide

Substanzen

Amyloid beta-PeptidesDiterpenesCytokinestriptolideEpoxy CompoundsPhenanthrenes

Autor:innen und Institutionen

  • Department of Neurology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Department of Neurology, Sinopharm Dongfeng General Hospital, Jinzhou Medical University Union Training Base, Jinzhou, China.
  • Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Department of Anesthesiology, Sinopharm Dongfeng General Hospital, Jinzhou Medical University Union Training Base, Jinzhou, China.
  • Department of Orthopedics, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Zitieren

APA

Mao, R., Xu, S., Sun, G., Yu, Y., Zuo, Z., Wang, Y., Yang, K., Zhang, Z., & Yang, W. (2023). Triptolide injection reduces Alzheimer's disease‐like pathology in mice. Synapse. https://doi.org/10.1002/syn.22261

Vancouver

Mao R, Xu S, Sun G, Yu Y, Zuo Z, Wang Y, et al. Triptolide injection reduces Alzheimer's disease‐like pathology in mice. Synapse. 2023. doi:10.1002/syn.22261

BibTeX
@article{Mao2023,
  author = {Mao, Rui and Xu, Shihao and Sun, Guangwen and Yu, Yingying and Zuo, Zhiyi and Wang, Yuanyuan and Yang, Kun and Zhang, Zhen and Yang, Wenqiong},
  title = {Triptolide injection reduces Alzheimer's disease‐like pathology in mice},
  journal = {Synapse},
  year = {2023},
  doi = {10.1002/syn.22261}
}
Kostenlos starten →